This brand name is authorized in Austria, Ecuador
The drug CUSTODIOL contains a combination of these active pharmaceutical ingredients (APIs):
1
Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE
|
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. |
2
Potassium chloride (E508)
UNII 660YQ98I10 - POTASSIUM CHLORIDE
|
Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism. |
3
Magnesium chloride hexahydrate
UNII 02F3473H9O - MAGNESIUM CHLORIDE
|
|
4
Histidine hydrochloride
UNII 1D5Q932XM6 - HISTIDINE MONOHYDROCHLORIDE
|
|
5
Histidine
UNII 4QD397987E - HISTIDINE
|
|
6
Tryptophan
UNII 8DUH1N11BX - TRYPTOPHAN
|
|
7
Mannitol (E421)
UNII 3OWL53L36A - MANNITOL
|
Mannitol is a naturally occurring sugar alcohol used clinically primarily for its osmotic diuretic properties. |
8
Calcium chloride dihydrate
UNII M4I0D6VV5M - CALCIUM CHLORIDE
|
Calcium is the most abundant mineral in the body, and is an essential body electrolyte. Homeostasis is mainly regulated by the parathyroid hormone, by calcitonin, and by the activated form of vitamin D. Calcium is a structural component of bones and teeth. It is also required for blood clotting, neurotransmitter release, muscle contraction and normal heartbeat. |
9
Ketoglutaric acid
UNII 8ID597Z82X - OXOGLURIC ACID
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
B05XA16 | Cardioplegia solutions | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05X I.V. solution additives → B05XA Electrolyte solutions |
V07AB | Solvents and diluting agents, incl. irrigating solutions | V Various → V07 All other non-therapeutic products → V07A All other non-therapeutic products |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EC | Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria | Identifier(s): 2628-MEE-0317 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.